FLUDEOXYGLUCOSE F-18 300 mCi/mL
FLUDEOXYGLUCOSE F-18 · INJECTION · Barbara Ann Karmanos Cancer Hospital
FLUDEOXYGLUCOSE F-18 is a injection containing fludeoxyglucose f-18 at 300 mCi/mL, taken intravenous. Manufactured by Barbara Ann Karmanos Cancer Hospital.
Key Facts
- Brand Name
- FLUDEOXYGLUCOSE F-18
- Generic Name
- FLUDEOXYGLUCOSE F-18
- NDC Code (Product)
78714-001- Manufacturer
- Barbara Ann Karmanos Cancer Hospital
- Strength
- 300 mCi/mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- ANDA204385
- Drug Class
- Radioactive Diagnostic Agent [EPC]
- Marketing Start
- 01/31/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is FLUDEOXYGLUCOSE F-18 used for?
FLUDEOXYGLUCOSE F-18 contains FLUDEOXYGLUCOSE F-18. It is a injection taken intravenous. Consult your doctor for specific uses.
Is FLUDEOXYGLUCOSE F-18 a controlled substance?
FLUDEOXYGLUCOSE F-18 is not classified as a controlled substance by the DEA.
What is the generic name for FLUDEOXYGLUCOSE F-18?
The generic name for FLUDEOXYGLUCOSE F-18 is FLUDEOXYGLUCOSE F-18. There are 11 other brand versions of FLUDEOXYGLUCOSE F-18.
What is the NDC code for FLUDEOXYGLUCOSE F-18 300 mCi/mL?
The NDC (National Drug Code) for FLUDEOXYGLUCOSE F-18 300 mCi/mL is 78714-001, listed by Barbara Ann Karmanos Cancer Hospital.
Other Fludeoxyglucose Brands
See all →- Fludeoxyglucose F18300 mCi/mL24562-003
- Fludeoxyglucose F 1840 mCi/mL29998-001
- Fludeoxyglucose F 18240 mCi/mL52670-551
- Fludeoxyglucose F 18300 mCi/mL49609-101
- Fludeoxyglucose F 18300 mCi/mL24562-001
- Fludeoxyglucose F 18400 mCi/mL81759-001
- Fludeoxyglucose F-18500 mCi/mL52768-001
- Fludeoxyglucose F 18300 mCi/mL76318-334
- FLUDEOXYGLUCOSE F 18300 mCi/mL24417-001
- Fludeoxyglucose F-18500 mCi/mL65857-150
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)